From: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups
 | Luminalb, d | HER2-positiveb, d | Triple-negativeb, d | All subtypes |
---|---|---|---|---|
Race/Ethnicity | Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) | Percentage (95% CI) |
White, age 40 | Â | Â | Â | Â |
   To age 50 | 0.87 (0.84, 0.90) | 0.27 (0.25, 0.29) | 0.17 (0.16, 0.19) | 1.57 (1.52, 1.61) |
   To age 70 | 4.54 (4.45, 4.63) | 1.13 (1.09, 1.18) | 0.76 (0.72, 0.79) | 7.78 (7.67, 7.90) |
   To end of life | 8.00 (7.87, 8.14) | 1.74 (1.68, 1.80) | 1.19 (1.14, 1.24) | 13.6 (13.5, 13.8) |
Black, age 40 | Â | Â | Â | Â |
   To age 50 | 0.59 (0.52, 0.66) | 0.31 (0.26, 0.37) | 0.34 (0.29, 0.40) | 1.51 (1.40, 1.63) |
   To age 70 | 2.83 (2.63, 3.03) | 1.19 (1.07, 1.33) | 1.31 (1.18, 1.45) | 6.49 (6.02, 6.80) |
   To end of life | 4.55 (4.35, 4.76) | 1.73 (1.55, 1.92) | 1.91 (1.73, 2.11) | 10.7 (10.3, 11.2) |
Hispanic, age 40 | Â | Â | Â | Â |
   To age 50 | 0.49 (0.46, 0.52) | 0.23 (0.21, 0.25) | 0.16 (0.14, 0.17) | 1.07 (1.03, 1.12) |
   To age 70 | 2.49 (2.38, 2.59) | 0.94 (0.88, 1.01) | 0.65 (0.60, 0.71) | 4.99 (4.85, 5.14) |
   To end of life | 4.79 (4.59, 5.00) | 1.50 (1.39, 1.61) | 0.98 (0.90, 1.07) | 8.83 (8.56, 9.11) |
Asian, age 40 | Â | Â | Â | Â |
   To age 50 | 0.71 (0.66, 0.77) | 0.34 (0.30, 0.38) | 0.10 (0.08, 0.12) | 1.41 (1.34, 1.49) |
   To age 70 | 2.81 (2.68, 2.95) | 1.28 (1.19, 1.37) | 0.45 (0.40, 0.51) | 5.67 (5.47, 5.87) |
   To end of life | 4.92 (4.66, 5.20) | 1.70 (1.66, 1.97) | 0.72 (0.63, 0.84) | 9.68 (9.31, 10.1) |
All races, age 40 | Â | Â | Â | Â |
   To age 50 | 0.72 (0.70, 0.74) | 0.27 (0.26, 0.28) | 0.17 (0.16, 0.18) | 1.41 (1.38, 1.44) |
   To age 70 | 3.72 (3.66, 3.78) | 1.12 (1.08, 1.15) | 0.73 (0.70, 0.76) | 6.83 (6.75, 6.91) |
   To end of life | 6.74 (6.64, 6.84) | 1.70 (1.66, 1.75) | 1.14 (1.10, 1.18) | 12.1 (12.0, 12.3) |